Literature DB >> 16641221

Mouse models for investigating the developmental basis of human birth defects.

Anne M Moon1.   

Abstract

Clinicians and basic scientists share an interest in discovering how genetic or environmental factors interact to perturb normal development and cause birth defects and human disease. Given the complexity of such interactions, it is not surprising that 4% of human infants are born with a congenital malformation, and cardiovascular defects occur in nearly 1%. Our research is based on the fundamental hypothesis that an understanding of normal and abnormal development will permit us to generate effective strategies for both prevention and treatment of human birth defects. Animal models are invaluable in these efforts because they allow one to interrogate the genetic, molecular and cellular events that distinguish normal from abnormal development. Several features of the mouse make it a particularly powerful experimental model: it is a mammalian system with similar embryology, anatomy and physiology to humans; genes, proteins and regulatory programs are largely conserved between human and mouse; and finally, gene targeting in murine embryonic stem cells has made the mouse genome amenable to sophisticated genetic manipulation currently unavailable in any other model organism.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16641221      PMCID: PMC1780035          DOI: 10.1203/01.pdr.0000218420.00525.98

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  39 in total

1.  DiGeorge syndrome phenotype in mice mutant for the T-box gene, Tbx1.

Authors:  L A Jerome; V E Papaioannou
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

2.  TBX1 is responsible for cardiovascular defects in velo-cardio-facial/DiGeorge syndrome.

Authors:  S Merscher; B Funke; J A Epstein; J Heyer; A Puech; M M Lu; R J Xavier; M B Demay; R G Russell; S Factor; K Tokooya; B S Jore; M Lopez; R K Pandita; M Lia; D Carrion; H Xu; H Schorle; J B Kobler; P Scambler; A Wynshaw-Boris; A I Skoultchi; B E Morrow; R Kucherlapati
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

3.  Tbx1 haploinsufficieny in the DiGeorge syndrome region causes aortic arch defects in mice.

Authors:  E A Lindsay; F Vitelli; H Su; M Morishima; T Huynh; T Pramparo; V Jurecic; G Ogunrinu; H F Sutherland; P J Scambler; A Bradley; A Baldini
Journal:  Nature       Date:  2001-03-01       Impact factor: 49.962

4.  Mice lacking the homologue of the human 22q11.2 gene CRKL phenocopy neurocristopathies of DiGeorge syndrome.

Authors:  D L Guris; J Fantes; D Tara; B J Druker; A Imamoto
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

5.  Fgf8 signalling from the AER is essential for normal limb development.

Authors:  M Lewandoski; X Sun; G R Martin
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

6.  Widespread recombinase expression using FLPeR (flipper) mice.

Authors:  F W Farley; P Soriano; L S Steffen; S M Dymecki
Journal:  Genesis       Date:  2000 Nov-Dec       Impact factor: 2.487

7.  Fgf8 is required for outgrowth and patterning of the limbs.

Authors:  A M Moon; M R Capecchi
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

8.  Conditional inactivation of Fgf4 reveals complexity of signalling during limb bud development.

Authors:  X Sun; M Lewandoski; E N Meyers; Y H Liu; R E Maxson; G R Martin
Journal:  Nat Genet       Date:  2000-05       Impact factor: 38.330

9.  Normal limb development in conditional mutants of Fgf4.

Authors:  A M Moon; A M Boulet; M R Capecchi
Journal:  Development       Date:  2000-03       Impact factor: 6.868

Review 10.  Fibroblast growth factors.

Authors:  D M Ornitz; N Itoh
Journal:  Genome Biol       Date:  2001-03-09       Impact factor: 13.583

View more
  8 in total

1.  Fetal and postnatal lung defects reveal a novel and required role for Fgf8 in lung development.

Authors:  Shibin Yu; Bryan Poe; Margaret Schwarz; Sarah A Elliot; Kurt H Albertine; Stephen Fenton; Vidu Garg; Anne M Moon
Journal:  Dev Biol       Date:  2010-08-19       Impact factor: 3.582

Review 2.  Cardiac developmental toxicity.

Authors:  Gretchen J Mahler; Jonathan T Butcher
Journal:  Birth Defects Res C Embryo Today       Date:  2011-12

3.  Fibronectin signals through integrin α5β1 to regulate cardiovascular development in a cell type-specific manner.

Authors:  Dongying Chen; Xia Wang; Dong Liang; Julie Gordon; Ashok Mittal; Nancy Manley; Karl Degenhardt; Sophie Astrof
Journal:  Dev Biol       Date:  2015-10-03       Impact factor: 3.582

Review 4.  Optical Coherence Tomography for live imaging of mammalian development.

Authors:  Irina V Larina; Kirill V Larin; Monica J Justice; Mary E Dickinson
Journal:  Curr Opin Genet Dev       Date:  2011-09-29       Impact factor: 5.578

5.  Mouse and human phenotypes indicate a critical conserved role for ERK2 signaling in neural crest development.

Authors:  Jason Newbern; Jian Zhong; Rasika S Wickramasinghe; Xiaoyan Li; Yaohong Wu; Ivy Samuels; Natalie Cherosky; J Colleen Karlo; Brianne O'Loughlin; Jamie Wikenheiser; Madhusudhana Gargesha; Yong Qiu Doughman; Jean Charron; David D Ginty; Michiko Watanabe; Sulagna C Saitta; William D Snider; Gary E Landreth
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-24       Impact factor: 11.205

6.  Mesodermal expression of integrin α5β1 regulates neural crest development and cardiovascular morphogenesis.

Authors:  Dong Liang; Xia Wang; Ashok Mittal; Sonam Dhiman; Shuan-Yu Hou; Karl Degenhardt; Sophie Astrof
Journal:  Dev Biol       Date:  2014-09-19       Impact factor: 3.582

7.  Neural crest cell-autonomous roles of fibronectin in cardiovascular development.

Authors:  Xia Wang; Sophie Astrof
Journal:  Development       Date:  2015-11-09       Impact factor: 6.868

Review 8.  Mouse embryo phenotyping with optical coherence tomography.

Authors:  Deirdre M Scully; Irina V Larina
Journal:  Front Cell Dev Biol       Date:  2022-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.